Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

被引:124
作者
Gómez-Ramos, A
Díaz-Nido, J
Smith, MA
Perry, G
Avila, J
机构
[1] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
GSK3; p38; acrolein; tau; phosphorylation sites;
D O I
10.1002/jnr.10525
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A hallmark of several neurodegenerative disorders, including Alzheimer's disease and tauopathies, is the hyperphosphorylation of the microtubule-associated protein tau. Tau phosphorylation by proline-directed and non-proline-directed protein kinases has been tested using antibodies PHF1 and 12E8, respectively. The effect of the lipid peroxidation product acrolein on these modes of phosphorylation has been assayed. We have found that acrolein, a peroxidation product from arachidonic acid, increases the phosphorylation of tau at the site recognized by PHF-1 both in human neuroblastoma cells and in primary cultures of mouse embryo cortical neurons. Whereas the basal phosphorylation of tau protein at the PHF1 site seems to be largely mediated by glycogen synthase kinase-3 (which is also activated in response to Abeta peptide), the acrolein-induced tau hyperphosphorylation at the same site is also due to p38 stress-activated kinase. These results support the view that oxidative stress and subsequent formation of lipid peroxidation products may contribute to tau protein phosphorylation in Alzheimer's disease and tauopathies. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 38 条
[1]   Lithium protects cultured neurons against β-amyloid-induced neurodegeneration [J].
Alvarez, G ;
Muñoz-Montaño, JR ;
Satrústegui, J ;
Avila, J ;
Bogónez, E ;
Díaz-Nido, J .
FEBS LETTERS, 1999, 453 (03) :260-264
[2]   Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis [J].
Atzori, C ;
Ghetti, B ;
Piva, R ;
Srinivasan, AN ;
Zolo, P ;
Delisle, MB ;
Mirra, SS ;
Migheli, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (12) :1190-1197
[3]  
BAUDIER J, 1987, J BIOL CHEM, V262, P17577
[4]   ABNORMAL ALZHEIMER-LIKE PHOSPHORYLATION OF TAU-PROTEIN BY CYCLIN-DEPENDENT KINASES CDK2 AND CDK5 [J].
BAUMANN, K ;
MANDELKOW, EM ;
BIERNAT, J ;
PIWNICAWORMS, H ;
MANDELKOW, E .
FEBS LETTERS, 1993, 336 (03) :417-424
[5]  
BIEDLER JL, 1978, CANCER RES, V38, P3751
[6]   Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease [J].
Calingasan, NY ;
Uchida, K ;
Gibson, GE .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :751-756
[7]  
CORREAS I, 1992, J BIOL CHEM, V267, P15721
[8]   Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies [J].
Ferrer, I ;
Blanco, R ;
Carmona, M ;
Puig, B .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (12) :1397-1415
[9]   Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? [J].
Finkelstein, EI ;
Nardini, M ;
Van der Vliet, A .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (03) :L732-L739
[10]   Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases [J].
Goedert, M ;
Hasegawa, M ;
Jakes, R ;
Lawler, S ;
Cuenda, A ;
Cohen, P .
FEBS LETTERS, 1997, 409 (01) :57-62